Biggest News Aggregation in the World
๐Ÿ“ฐ Medication Guide News

Page 19 - Medication Guide News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Medication Guide. Real-time updates on events, politics, business and more.

FDA Approves Genentech's Columvi, the First and Only Bispecific Antibody With a Fixed-Duration Treatment for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

- Pivotal study showed durable responses, with a 56% overall response rate, a 43% complete response (remission) rate, and a median duration of response of 1.5 years (18.4 months) - - Given over
United States South San Francisco Bruno Eschli Loren Kalm Lindsey Mathias Levi Garraway

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023

Results from phase 1/2 EPCORE NHL-2 trial investigating epcoritamab in combination with rituximab-lenalidomide (R2) showed a 98 percent overall response rate (ORR), 87 percent complete metabolic
United States Lhospitalet De Llobregat Comunidad Autonoma De Cataluna New Jersey Andrew Carlsen Judith Klimovsky

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science